STRO - Sutro Biopharma

-

$undefined

N/A

(N/A)

Sutro Biopharma NASDAQ:STRO Sutro Biopharma, Inc., located in South San Francisco, is a clinical-stage drug discovery, development and manufacturing company. Using precise protein engineering and rational design, Sutro is advancing next-generation oncology therapeutics.

Location: 310 Utah Ave Ste 150, California, 94080-6803, US | Website: www.sutrobio.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-218.1M

Cash

316.9M

Avg Qtr Burn

-47.89M

Short % of Float

7.66%

Insider Ownership

4.11%

Institutional Own.

79.73%

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 3

Data readout

Phase 2/3

Update

Phase 2

Update

Phase 1b

Update

M1231 (MUC1-EGFR Bispecific ADC) Details
Solid tumor/s, Esophageal cancer, Non-small cell lung carcinoma, Cancer

Failed

Discontinued

STRO-001 (BN301) (CD74-Targeting ADC) Details
Cancer, B-cell lymphoma, Follicular lymphoma, Lymphoma, Mantle cell lymphoma

Failed

Discontinued